Immunodermatology News

Nomacopan was well tolerated and beneficial in patients with bullous pemphigoid, according to phase 2a clinical trial results.

DESTIN, Fla. — Hydroxychloroquine may no longer be the optimal treatment option for systemic dermatomyositis, according to data presented at the Congress of Clinical Rheumatology East.

In this video, Yemi Sokumbi, MD, discusses session highlights from the American Academy of Dermatology Annual Meeting.

Hidradenitis suppurativa patients treated with intense pulsed light with radiofrequency had a statistically significant, but not clinically important, improvement in quality of life, according to a study.

Patients with hidradenitis suppurativa who reported internalized skin bias were also likely to report anxiety, depression and impaired overall quality of life, according to a study.

The diagnosis, treatment, and long-term monitoring of patients with autoinflammatory type 1 interferonopathies require a multidisciplinary approach, according to joint guidelines released by EULAR and the American College of Rheumatology.

In this video, Haley Naik, MD, discusses “three key themes” from the hidradenitis suppurativa symposiums at the American Academy of Dermatology Annual Meeting.

In this video, Haley Naik, MD, highlights the surgical management of hidradenitis suppurativa session at the American Academy of Dermatology Annual Meeting.

In this video, Haley Naik, MD, spoke with Healio about a patient-led presentation on hidradenitis suppurativa at the American Academy of Dermatology Annual Meeting.

Researchers found that long-term remission of cutaneous lupus erythematosus occurred in nearly 20% of patients, according to a study published in the Journal of American Academy of Dermatology.